 |
|
|
|
 |
|
|
| Article 1 to 10 out of 45 concerning GlaxoSmithKline plc (GSK)
|
-
Global Vaccine Market Forecast to 2012
(09 Oct 2008)
Examine This Global Vaccine Market Forecast to 2012 as the Market is Expected to Emerge as the Fastest Growing Therapy Area in the Next 5 Years
Research and Markets has announced the addition of the "Global Vaccine Market Forecast to 2012" report to their offering."Global Vaccine Market Forecast to 2012”, our new research report, states that vaccines, which were earlier thought as a low ...
-
GlaxoSmithKline and Cellzome Announce Major Strategic Alliance
(15 Sep 2008)
Kinobeads(TM) Technology to Identify a New Generation of Drug
Cellzome Inc. and GlaxoSmithKline announced the signing of a worldwide strategic alliance to discover, develop and market novel kinase-targeted therapeutics to treat inflammatory diseases.The alliance gives GSK access to Cellzome's significant ...
-
Researchers locate geographic origins from DNA
(05 Sep 2008)
One day soon, you may be able to pinpoint the geographic origins of your ancestors based on analysis of your DNA
A study published in Nature by an international team that included Cornell researchers describes the use of DNA to predict the geographic origins of individuals from a sample of Europeans, often within a few hundred kilometers of where they were ...
-
Valeant Pharmaceuticals and GlaxoSmithKline Announce Worldwide Collaboration Agreement for Retigabine
(01 Sep 2008)
GSK to make upfront payment to Valeant of $125 million
Valeant Pharmaceuticals International and GlaxoSmithKline (GSK) announced that they have entered into an exclusive worldwide collaboration agreement for the investigational drug retigabine, a first in class neuronal potassium channel opener for ...
-
Actelion and GlaxoSmithKline enter into exclusive collaboration to realise the full potential of almorexant in sleep disorders
(15 Jul 2008)
Actelion and GlaxoSmithKline (GSK) to potentially co-develop and co-commercialise other orexin receptor antagonists
Actelion Ltd and GlaxoSmithKline announced that they have entered into an exclusive worldwide collaboration (excluding Japan) for Actelion's almorexant, an orexin receptor antagonist in phase III development with first-in-class potential as a ...
-
Galapagos announces milestone payment of EUR0.8 million in osteoarthritis alliance with GlaxoSmithKline
(17 Jun 2008)
Galapagos NV announced that it has reached two new milestones in its multi-year drug discovery alliance with GlaxoSmithKline in osteoarthritis, triggering a payment of EUR0.8 million from GSK.In June 2006, GSK's Center of Excellence for External ...
-
Genmab reaches milestones in ofatumumab collaboration
(23 Jan 2008)
Genmab A/S (OMX: GEN) announced it has reached the second and third development milestones for ofatumumab (HuMax-CD20®) under the terms of its collaboration with GlaxoSmithKline (GSK). The second milestone payment of the collaboration of DKK 87.2 ...
-
GlaxoSmithKline and Galapagos enter strategic alliance to develop novel antibacterials and antivirals
(11 Dec 2007)
Discovery and development of novel anti-infective medicines based on Galapagos' natural product drug discovery platform
GlaxoSmithKline (GSK) and Galapagos NV announced the creation of a multi-year strategic alliance to develop novel anti-infective drug candidates. GlaxoSmithKline will participate in the alliance through its Infectious Diseases Centre of Excellence ...
-
OncoMethylome Sciences to Collaborate with GlaxoSmithKline Biologicals for Personalized Cancer Treatment
(27 Nov 2007)
OncoMethylome Sciences announced that it has entered into a collaboration with GlaxoSmithKline (GSK) Biologicals. The goal of the collaboration is to develop DNA methylation biomarkers for use in the personalization of cancer treatment with certain ...
-
GlaxoSmithKline announces USD 1.65 billion of acquisition Reliant Pharmaceutical
(23 Nov 2007)
Pronova BioPharma ASA notes the announcement of a proposed USD 1.65 billion acquisition between GlaxoSmithKline PLC and Reliant Pharmaceuticals, Inc. GlaxoSmithKline is one of the world`s leading research-based pharmaceutical and healthcare ...
Additional information
GlaxoSmithKline plc (GSK)
Brentford, Middlesex, United Kingdom
Company
|
|
|
|
|
|
Top
